CLEAR CC for Bladder Cancer

University of Michigan Rogel Cancer Center, Ann Arbor, MI
Bladder Cancer+1 More ConditionsCLEAR Care Companion (CC) application - Behavioral
All Sexes

Study Summary

This trial uses a smartphone app to help prevent readmissions after major cancer surgery, improving outcomes, reducing mortality, and saving costs.

Eligible Conditions
  • Bladder Cancer
  • Radical Cystectomy

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3

Study Objectives

5 Primary · 3 Secondary · Reporting Duration: 42 days post hospital discharge

Day 42
Duration of engagement with application
Frequency of engagement with application
Patient Experience Survey -- Application (all participants)
Patient Experience Survey -- Application (first 20 participants)
Patient Experience Survey -- Overall Care (all participants)
Patient Experience Survey -- Overall Care (first 20 participants)
Readmission intensity
Readmission rate

Trial Safety

Phase-Based Safety

1 of 3

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

1 Treatment Group

1 of 1

Experimental Treatment

250 Total Participants · 1 Treatment Group

Primary Treatment: CLEAR CC · No Placebo Group · N/A

Experimental Group · 1 Intervention: CLEAR Care Companion (CC) application · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 42 days post hospital discharge

Who is running the clinical trial?

University of Michigan Rogel Cancer CenterLead Sponsor
272 Previous Clinical Trials
18,311 Total Patients Enrolled
Jeffery Montgomery, M.D.Principal InvestigatorUniversity of Michigan Rogel Cancer Center

Eligibility Criteria

Age 18+ · All Participants · 0 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Frequently Asked Questions

Are there opportunities for newly enrolled participants to join this trial?

"Indeed, indicates that this medical experiment has been opened and is now recruiting participants since December 1st 2022. The last update to the study was November 8th 2022, with an aim of enrolling 250 patients at a single location." - Anonymous Online Contributor

Unverified Answer

To what extent is this trial populated with participants?

"Affirmative. confirms that this clinical trial, which was first made public on December 1st 2022, is currently recruiting participants for the study. 250 participants are required to join from a single medical centre." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.